Prognostic factors in metastatic prostate cancer

被引:17
|
作者
Yigitbasi, Orhan [1 ]
Ozturk, Ufuk [1 ]
Goktug, H. N. Goksel [1 ]
Gucuk, Adnan [1 ]
Bakirtas, Hasan [1 ]
机构
[1] Ankara Diskapt Yildirun Beyazit Educ & Res Hosp, Minist Hlth, Ankara, Turkey
关键词
Metastatic prostate cancer; Prostate specific antigen; Gleason score; Prognostic factor; ANTIGEN;
D O I
10.1016/j.urolonc.2009.03.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Aim of this study is to determine the prognostic value of age, serum alkaline phosphatase, pretreatment PSA level, Gleason score, and number of bone metastasis focuses. Patients and methods: One hundred fifty-one patients who had been followed in our clinic between years 1989 and 2006 were investigated retrospectively. Results: As a result of this study, it has been detected that serum alkaline phosphatase, Gleason score, and intensity of bone metastasis are important and statistically significant prognostic factors, and affects time to progression and life time. But pretreatment PSA level, and age have been detected not to be effective in predicting time to progression and life time. Conclusion: Metastatic prostate cancer provides a wide spectrum for risk of death from the disease, and clinicians have long sought Methods to predict the outcome accurately in individual patients. In our study, we found that high serum alkaline phosphatase, high Gleason score, and intense bone metastasis (>6) has negative impact on progression and survival. (C) 2011 Published by Elsevier Inc.
引用
收藏
页码:162 / 165
页数:4
相关论文
共 50 条
  • [41] Prognostic factors in the pathological assessment of prostate cancer
    Murphy, WM
    [J]. HUMAN PATHOLOGY, 1998, 29 (05) : 427 - 430
  • [42] Immunopathological prognostic and predictive factors in prostate cancer
    Sivridis E.
    Touloupidis S.
    Giatromanolaki A.
    [J]. International Urology and Nephrology, 2002, 34 (1) : 63 - 71
  • [43] Molecular biomarkers and prognostic factors for prostate cancer
    Kretschmer, A.
    Tolkach, Y.
    Ellinger, J.
    Kristiansen, G.
    [J]. UROLOGE, 2017, 56 (07): : 933 - 943
  • [44] Diagnostic and prognostic factors in patients with prostate cancer
    Beyer, K.
    Moris, L.
    Lardas, M.
    Haire, A.
    Barletta, F.
    Scuderi, S.
    Molnar, M.
    Herrera, R.
    Rauf, A.
    Campi, R.
    Greco, I.
    Shiranov, K.
    Dabestani, S.
    Van den Broeck, T.
    Gacci, M.
    Gandaglia, G.
    Omar, M. I.
    Maclennan, S.
    Roobol, M. J.
    Zong, J.
    Maclennan, S. J.
    Collette, L.
    Briganti, A.
    Bjartell, A.
    Van Hemelrijck, M.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S428 - S429
  • [45] Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer
    Aragon-Ching, Jeanny B.
    Gillespie, John
    Price, Douglas K.
    Chuaqui, Rodrigo
    Rodriguez-Canales, Jaime
    Steinberg, Seth M.
    Dahut, William L.
    Figg, William D.
    [J]. BJU INTERNATIONAL, 2007, 100 (06) : 1245 - 1248
  • [46] Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
    Nishimoto, Mitsuhisa
    Fujita, Kazutoshi
    Yamamoto, Yutaka
    Hashimoto, Mamoru
    Adomi, Shogo
    Banno, Eri
    Saito, Yoshitaka
    Shimizu, Nobutaka
    Mori, Yasuuori
    Minami, Takafumi
    Nozawa, Masahiro
    Nose, Kazuhiro
    Hirayama, Akihide
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (08) : 2681 - 2687
  • [47] Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer
    Narita, Shintaro
    Nomura, Kyoko
    Hatakeyama, Shingo
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mitsuzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Nagashima, Kengo
    Habuchi, Tomonori
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [48] CHANGES IN THE CONDITIONAL NET SURVIVAL AND DYNAMIC PROGNOSTIC FACTORS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER
    Narita, Shintaro
    Nomura, Kyoko
    Hatakeyama, Shingo
    Takahashi, Masahiro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Ishida, Masanori
    Kawaguchi, Toshiaki
    Ishidoya, Shigeto
    Shimoda, Jiro
    Sato, Hiromi
    Mituzuka, Koji
    Tochigi, Tatsuo
    Tsuchiya, Norihiko
    Ohyama, Chikara
    Arai, Yoichi
    Nagashima, Kengo
    Habuchi, Tomonori
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E567 - E567
  • [49] Radium-223 treatment in Metastatic Prostate Cancer: Prognostic Factors: Real-world Outcome
    Pearson, R.
    Jiang, X.
    Atkinson, S.
    Cumming, S.
    Burns, A.
    Frew, J.
    McMenemin, R.
    Pedley, I.
    Azzabi, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S855 - S855
  • [50] Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Yokom, Daniel W.
    Stewart, John
    Alimohamed, Nimira S.
    Winquist, Eric
    Berry, Scott
    Hubay, Stacey
    Lattouf, Jean-Baptiste
    Leonard, Helene
    Girolametto, Carla
    Saad, Fred
    Sridhar, Srikala S.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (08): : E365 - E372